Health condition
Recurrent DVT investigations
A second (or third) deep vein thrombosis changes the conversation: investigations focus on why clots recur - inadequate anticoagulation, ongoing risk factors, antiphospholipid syndrome, anatomical compression or occult disease - and usually on long-term protection.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
First questions: was anticoagulation adequate and adhered to when the recurrence happened, and was the previous course long enough for that clot's circumstances?
-
Key tests after recurrence: antiphospholipid antibodies (the result that changes drug choice), consideration of anatomical causes (May-Thurner compression, past catheter sites), and clinical review for persisting drivers - obesity, immobility, oestrogens, inflammatory disease
-
Age-appropriate cancer screening review is standard after unprovoked recurrence; extensive blind scanning beyond this is not evidence-based
-
Specialist: a consultant haematologist; recurrent unprovoked VTE usually means indefinite anticoagulation, made safer by modern low-dose regimens
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
Recurrence reframes thrombosis from event to tendency, and the investigation is really three inquiries in parallel: circumstance analysis - whether the recurrence broke through therapeutic anticoagulation (which raises specific possibilities including antiphospholipid syndrome, cancer-associated clotting and anatomical factors) or arrived after treatment stopped, and whether the original course matched the original clot's provocation; laboratory work now clearly justified, led by antiphospholipid testing since a positive syndrome redirects both drug choice and duration; and a structured hunt for maintained drivers - weight, mobility, hormones, inflammatory conditions - plus confirmation that age-appropriate cancer screening is current, unprovoked recurrence being a recognised prompt to ensure it is, without descending into unfocused whole-body scanning that evidence does not support.
Diagnosis and treatment routes
Anatomy deserves particular thought in recurrent same-leg clots: left-sided recurrence raises May-Thurner syndrome (iliac vein compression), imaged with CT or MR venography and stentable where significant, while upper-limb recurrence looks to thoracic outlet anatomy and catheter history. The management outcome for most is indefinite anticoagulation - the arithmetic of high recurrence risk against modern regimens' low bleeding rates favours protection, made more comfortable by reduced-dose apixaban or rivaroxaban options after the initial phase - alongside compression assessment for post-thrombotic legs and an explicit plan for high-risk situations. Structured periodic review keeps the decision honest: bleeding risk, new diagnoses and patient priorities all evolve, and duration decisions deserve revisiting rather than fossilising. In many parts of the UK, routine NHS referrals for this kind of problem currently take 20-45+ weeks, whereas an initial appointment with a private consultant is typically available within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Recurrent DVT investigations.
Quick, plain-English answers to what people most often ask.
-
What does a recurrent DVT mean?
A recurrent deep vein thrombosis is a second or subsequent blood clot in a deep vein, and it shifts the focus of investigation onto why clots keep forming - whether treatment has been inadequate, risk factors persist, or an underlying clotting tendency exists.
-
What causes recurrent DVT?
Common contributors include inadequate or interrupted anticoagulation, ongoing risk factors such as immobility or cancer, antiphospholipid syndrome, anatomical vein compression, or an underlying occult illness such as cancer.
-
Is recurrent DVT dangerous?
Yes - each clot carries a risk of pulmonary embolism, and recurrence increases the long-term risk of chronic complications such as post-thrombotic syndrome, so proper investigation and often long-term anticoagulation are important.
-
How is recurrent DVT investigated?
Investigation typically includes blood tests for clotting disorders and antiphospholipid syndrome, imaging to check for vein compression or previous clot damage, and screening for underlying conditions such as cancer if not already done.
-
How is recurrent DVT treated?
Treatment usually means anticoagulation, often for a longer duration or indefinitely compared with a first clot, alongside addressing any specific cause identified, such as treating an underlying compression or cancer.
-
Recurrent DVT vs a first DVT - what's the difference?
A first DVT with a clear temporary trigger (such as surgery) is often treated for a defined period, whereas recurrence, or clots without an obvious trigger, generally prompts more thorough investigation and consideration of long-term anticoagulation.
-
When should I see a doctor about recurrent DVT?
Seek urgent care for symptoms of a new clot - leg swelling, pain or breathlessness - and ask for referral to a haematologist for investigation after any recurrence. A private consultant haematologist can typically be seen within about two weeks.